ToMorrow® gives dairy producers time-tested, broad-spectrum control
against the harmful organisms that cause mastitis in dry cows. ToMorrow®
has been an effective extended therapy treatment for more than 25 years,
and studies have shown no change in the development of bacterial
resistance.1,2ToMorrow® has been shown by extensive clinical studies to
be efficacious in the treatment o mastitis in dry cows, when caused by
Streptococcus agalactiae and Staphylococcus aureus, including
penicillin-resistant strains.
**For more information about the Guidance for Industry #263 transition,
please access our resource center:
https://www.animalhealthinternational.com/gfi-263-resource-center**
against the harmful organisms that cause mastitis in dry cows. ToMorrow®
has been an effective extended therapy treatment for more than 25 years,
and studies have shown no change in the development of bacterial
resistance.1,2ToMorrow® has been shown by extensive clinical studies to
be efficacious in the treatment o mastitis in dry cows, when caused by
Streptococcus agalactiae and Staphylococcus aureus, including
penicillin-resistant strains.
**For more information about the Guidance for Industry #263 transition,
please access our resource center:
https://www.animalhealthinternational.com/gfi-263-resource-center**
- (Loading SDS PDF) SDS Sheet